Timing of Noncardiac Surgery After Coronary Artery Stenting With Bare Metal or Drug-Eluting Stents

The current guidelines have recommended postponing noncardiac surgery (NCS) for ≥6 weeks after bare metal stent (BMS) placement and for ≥1 year after drug-eluting stent (DES) placement. However, much debate has ensued about these intervals. The aim of the present study was to assess the influence of...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2009-11, Vol.104 (9), p.1229-1234
Main Authors: van Kuijk, Jan-Peter, MD, Flu, Willem-Jan, MD, Schouten, Olaf, MD, PhD, Hoeks, Sanne E., MSc, Schenkeveld, Lisanne, MSc, de Jaegere, Peter P.T., MD, PhD, Bax, Jeroen J., MD, PhD, van Domburg, Ron T., PhD, Serruys, Patrick W., MD, PhD, Poldermans, Don, MD, PhD
Format: Article
Language:English
Subjects:
Angioplasty
Biological and medical sciences
Cardiology. Vascular system
Cardiovascular
Cardiovascular disease
Coronary Thrombosis - epidemiology
Diseases of the cardiovascular system
Drug therapy
Drug Therapy, Combination
Drug-Eluting Stents
Female
Hemorrhage - epidemiology
Humans
Male
Medical sciences
Metals
Middle Aged
Myocardial Infarction - epidemiology
Myocardial Ischemia - epidemiology
Myocardial Ischemia - therapy
Platelet Aggregation Inhibitors - therapeutic use
Postoperative Complications - epidemiology
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Retreatment
Stents
Studies
Surgery
Surgical Procedures, Operative - statistics & numerical data
Time Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The current guidelines have recommended postponing noncardiac surgery (NCS) for ≥6 weeks after bare metal stent (BMS) placement and for ≥1 year after drug-eluting stent (DES) placement. However, much debate has ensued about these intervals. The aim of the present study was to assess the influence of different intervals between stenting and NCS and the use of dual antiplatelet therapy on the occurrence of perioperative major adverse cardiac events (MACEs). We identified 550 patients (376 with a DES and 174 with a BMS) by cross-matching the Erasmus Medical Center percutaneous coronary intervention (PCI) database with the NCS database. The following intervals between PCI-BMS (
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2009.06.038